The Medicines and Healthcare products Regulatory Agency is developing guidance to regulate innovative mRNA therapies that utilize artificial intelligence for personalized cancer treatment, addressing safety, effectiveness, and post-approval monitoring in the UK.
View full story…
MHRA Establishes Regulatory Pathway for AI-Driven mRNA Cancer Therapies
